Abstract
Poliomyelitis is caused by poliovirus, which is a positive strand non-enveloped virus that occurs in three distinct serotypes (1, 2, and 3). Infection is mainly by the fecal–oral route and can be confined to the gut by antibodies induced either by vaccine, previous infection or maternally acquired. Vaccines include the live attenuated strains developed by Sabin and the inactivated vaccines developed by Salk; the live attenuated vaccine (Oral Polio Vaccine or OPV) has been the main tool in the Global Program of Polio eradication of the World Health Organisation. Wild type 2 virus has not caused a case since 1999 and type 3 since 2012 and eradication seems near. However most infections are entirely silent so that sophisticated environmental surveillance may be needed to ensure that the virus has been eradicated, and the live vaccine can sometimes revert to virulent circulating forms under conditions that are not wholly understood. Cessation of vaccination is therefore an increasingly important issue and inactivated polio vaccine (IPV) is playing a larger part in the end game.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Landsteiner K, Popper E (1909) Ubertragung der poliomyelitis scuta auf affen. Z Immunitatdforsch Exp Therap Orig 2:377–390
Paul JR (1971) A history of poliomyelitis. Yale University Press, New Haven
Minor PD (1997) Poliovirus. In: Nathanson N, Ahmed R, Ganzalez-Scarano F, Griffin DE, Holmes KV, Murphy FA, Robinson HL (eds) Viral pathogenesis. Lipincott Raven, Philadelphia, pp 555–574
Hammon WD, Coriell LL, Wehrle PF, Stokes J (1953) Evaluation of Red Cross gammaglobulin as a prophylactic agent for poliomyelitis. 4. Final report of results based on clinical diagnosis. JAMA 151:1272–1285
Mayer MM, Rapp HJ, Roizman B, Klein SW, Cowan KM, Lukens D, Schwerdt CE, Schaffer FL, Charney J (1957) The purification of poliomyelitis virus as studied by complement fixation. J Immunol 78:435–455
Le Bouvier GL (1959) The modification of poliovirus antigens by heat and ultraviolet light. Lancet 269(6898):1013–1016
Offit P (2005) The cutter incident: how America’s first polio vaccine led to the growing vaccine crisis. Yale University Press, New Haven. ISBN 0-300-10864-8
Shah K, Nathanson N (1976) Human exposure to SV40: review and comment. Am J Epidemiol 103:1–12
Minor PD (2012) The polio eradication programme and issues of the endgame. J Gen Virol 93:457–474
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Minor, P.D. (2016). An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication. In: MartÃn, J. (eds) Poliovirus. Methods in Molecular Biology, vol 1387. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3292-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3292-4_1
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3291-7
Online ISBN: 978-1-4939-3292-4
eBook Packages: Springer Protocols